An abnormal increase or decrease in blood pressure (BP) in response to postural stress is associated with increased risk of developing hypertension and stroke. However, the haemodynamic responses contributing to changes in central BP with postural stress are not well characterised. We aimed to determine this in controls compared to patients with type 2 diabetes mellitus (T2DM), whom we hypothesised would have an abnormal postural response. 41 participants (20 control, 21 T2DM) underwent measurement of brachial and central BP (by radial tonometry), with simultaneous bioimpedance cardiography (to determine stroke volume (SV) and cardiac output (CO)) and heart rate variability in seated and standing postures. Systemic vascular resistance (SVR; mean arterial pressure/CO), and arterial elastance (E A ; end systolic pressure/SV) were calculated. Postural changes were defined as seated minus standing values. Central pulse pressure (PP) was higher in patients with T2DM and did not change from seated-tostanding positions, whereas there was a significant decrease upon standing in controls (Po0.05). The change in central systolic BP (SBP) correlated with change in SVR and E A in controls (r ¼ 0.67 and 0.68, Po0.05, respectively), but not in patients with T2DM (r ¼ À 0.05 and r ¼ 0.03, P40.05, respectively). SV was the only significant correlate of change in central SBP in T2DM patients (r ¼ 0.62, Po0.05) and this was not observed in controls (r ¼ À 0.08 P40.05). We conclude that central haemodynamic responses to postural stress are altered in patients with T2DM and result in persistent elevation of central PP while standing. This may contribute to increased cardiovascular risk associated with T2DM.
INTRODUCTION
An abnormal increase or decrease in brachial blood pressure (BP) in response to standing from the seated or supine position is associated with increased risk of developing hypertension 1,2 and stroke. 3 The underlying haemodynamic mechanisms associated with this increased cardiovascular risk are unknown. Most studies on postural BP have only focused on changes to brachial BP. However, recent literature has highlighted that central BP differs from brachial BP owing to systolic pressure amplification and is an independent predictor of cardiovascular events and all-cause mortality. 4, 5 In healthy individuals, a number of reflex physiological responses occur upon standing, including a significant increase in heart rate. 6 This alone may be expected to increase systolic pressure amplification, 7, 8 such that central systolic BP (SBP) would be lower than brachial SBP. Indeed, we have recently shown such an effect in older patients receiving therapy for hypertension, where central SBP had a proportionally greater drop than brachial SBP when moving from a seated to standing posture. 9 Although the underlying haemodynamic mechanisms of a reduction in central BP upon standing are incompletely understood, we found that heart rate variability may be an influencing factor, 9 and Davis et al. 6 have suggested that a reduction in stroke volume and increase in systemic vascular resistance (SVR) may also have a role. Despite this, a comprehensive haemodynamic evaluation of the response to standing from the seated posture and correlates of change in central BP has not been characterised in healthy individuals, and this was the first aim of the study. We hypothesised that increased heart rate and reduced SVR associated with standing would result in a relative drop in central SBP compared with brachial SBP in healthy individuals. In contrast, patients with type 2 diabetes mellitus have impaired heart rate variability, 10 and upon standing may have relatively increased cardiac output. 11 This high-output from the heart could contribute to an abnormally raised central BP response to standing. Furthermore, many studies have identified that patients with type 2 diabetes mellitus have systemic vascular dysfunction, which may include increased large-artery stiffness (aortic pulse wave velocity (PWV)) and impaired nitric oxidemediated endothelial function. 10, 11 To our knowledge, the central haemodynamics of postural stress have never been described in patients with type 2 diabetes mellitus, and it was the second aim of this study to compare this with the healthy response. Greater understanding of these effects may have relevance to the increased cardiovascular risk associated with type 2 diabetes mellitus.
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METHODS
Subjects and protocol
A total of 51 consecutive participants from the local community were recruited via media advertisements for inclusion in this study. This sample included a group of control participants (n ¼ 30) and a group of patients who were otherwise healthy but diagnosed with type 2 diabetes mellitus (n ¼ 21). Exclusion criteria for controls were; a clinical history of diabetes, chronic kidney disease or coronary artery disease; prior physician diagnosis of hypertension, use of antihypertensive, lipid lowering or insulin-sensitising medication. These details were assessed by each participant completing a medical history questionnaire. Other exclusion criteria determined upon examination included; elevated office BP (X140/90 mm Hg) or fasting serum glucose (X5.6 mmol l À 1 ). Ten participants met these criteria and were excluded, leaving 20 healthy controls for analysis.
All haemodynamic measures were recorded at one visit to the Menzies Research Institute Tasmania. Before attendance, participants were asked to abstain from smoking and caffeine-containing products for a minimum of 3 hours prior and heavy exercise 24 h before testing. Medications were not withheld. Anthropometric and medical history data was collected, along with measurements of brachial BP, radial applanation tonometry (to derive central BP), non-invasive impedance cardiography (to derive CO and SV) recorded after at least 5 min in the seated and standing positions. PWV was measured in a supine position. Fasting blood samples were collected on a separate visit to the clinic (within a week of original visit). Each individual provided informed consent and ethical approval was obtained to undertake the study.
Postural protocol
All participants began the study in the supine posture on a hospital bed. The instrumentation process took B5 min during the time when the patient was resting still and silent. Following this, measures of aortic and brachial PWV were recorded in duplicate. Patients then moved into a seated posture (feet flat on floor, back and arm supported) and after 5 min, brachial BP was measured in duplicate, followed immediately by radial tonometry to derive central BP. During radial tonometry, haemodynamic parameters (CO and SV) were continuously monitored by bioimpedance cardiography. This measurement period typically lasted 2 min. Once completed, patients moved to a standing posture. After 5 min, brachial BP was again measured in duplicate with the left arm supported at an approximate level of the heart. Radial tonometry was recorded again, together with simultaneous bioimpedance cardiography as per the seated protocol.
Brachial BP Brachial BP was recorded using a validated automatic device 14 (Omron HEM-907; OMRON Europe B.V. (OMCE), Hoofddorp, The Netherlands), with an appropriately sized cuff as per the guidelines. 15 Central BP and arterial stiffness Central BP was synthesised using radial applanation tonometry and application of a valid 16, 17 and reproducible 18 generalised transfer function (SphygmoCor 8.1, AtCor Medical, Sydney, Australia). Central pressure waveforms were calibrated using the systolic and diastolic BP values obtained from the brachial BP measurements performed immediately before waveform acquisition. Pulse pressure (PP) was defined as systolicdiastolic BP. PP amplification was defined as the ratio of brachial to central PP. Augmentation pressure was calculated from the central pressure waveform (second systolic peak to first systolic peak) as P2-P1, and expressed as a percentage of the PP for definition of augmentation index. Arterial stiffness (PWV) was determined using electrocardiogram-gated hand-held applanation tonometry (SphygmoCor 8.1, AtCor Medical). PWV is a measure of regional artery stiffness. Brachial PWV was determined from sequential carotid and radial waveforms, whereas aortic PWV was determined from sequential carotid and femoral waveforms.
Impedance cardiography SV and CO were derived using a commercial impedance device (Physio Flow; Manatec Biomedical; Macheren, France). 19 This non-invasive technique involves placement of six electrodes over the thorax, which measure changes in impedance signals during cardiac ejection to derive SV. Measurements were derived from the average of a 2-min period corresponding to the time of central pressure waveform acquisition. Parameters relating to ventricular-vascular coupling were calculated from a combination of bioimpedance and central BP data. Effective arterial elastance (E A ) was defined as the ratio of central end-systolic pressure and SV. Left ventricular end-systolic elastance (E LV ) was defined by the ratio of central end-systolic pressure to end-systolic volume (calculated as end-diastolic volume-SV). Ventricular-vascular coupling was calculated as the ratio E A /E LV . SVR was calculated by the quotient of mean arterial pressure and CO. 5, 20 Blood biochemistry Blood biochemistry analysis of plasma glucose, insulin, total cholesterol, high-density lipoprotein and triglyceride levels was performed via standard hospital pathology procedures.
Statistical analysis
All data were analysed using SPSS for windows software version 17.0 (SPSS Inc., Chicago, IL, USA). Data are expressed as mean ± s.d. unless otherwise stated. Between-group continuous variables were analysed using independent t-tests and categorical variables by the w 2 -test for independence. Analysis of covariance, with Bonferroni mixed-and between-group comparisons, was undertaken to correct for potential confounding variables. Pearson's product moment correlations were performed to assess relationships between variables. Z statistic scores were calculated, comparing the regression slopes obtained from within-group variable correlations. Normality of distribution was visually checked and confirmed via the Kolmogorov-Smirnov measure and/or Q-Q distribution plots for each variable included in the analysis. Po0.05 was considered statistically significant. From our previous reproducibility work, 18 we calculated that a between-group difference of 10 mm Hg in central SBP could be detected with 20 subjects per group (a ¼ 0.05 and b ¼ 0.20).
RESULTS
Clinical characteristics
The clinical characteristics of all patients are presented in Table 1 . Patients with T2DM were older, had a greater aortic PWV and increased plasma-glucose concentration compared with controls Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.
Central haemodynamics and postural stress MG Schultz et al (Po0.05 for all). Fifty-seven percent of patients with T2DM were hypertensive, 52% were using antihypertensive therapy and 74% were taking insulin-secretagogues or sensitising agents (metformin and/or sulfonylurea). The mean duration of T2DM was 11±8 years.
Haemodynamic response to standing The haemodynamic response to movement from the seated to standing posture is presented in Table 2 . One control and two participants with T2DM were excluded from the analysis of haemodynamic data because of poor-quality impedance recordings. For the controls, there were no significant changes in brachial or central SBP, diastolic BP, mean arterial pressure, augmentation index, brachial PP or SV when moving from the seated to standing posture. However, there were significant reductions in central PP ( Figure 1 ) and SVR, together with significant increases in HR and CO upon standing (P o0.05 for all). Contrary to controls, there were no statistically significant changes in any haemodynamic variable, including brachial or central SBP and central PP (Figure 1 ) when moving from the seated to standing posture in patients with T2DM, (P40.05 for all).
Haemodynamic response to standing: controls vs type 2 diabetes In the seated posture, patients with T2DM had significantly higher brachial and central SBP, mean arterial pressure, central and brachial PP, HR, CO and E A /E LV compared with control participants, while SVR was lower in patients with T2DM (Po0.05 for all). However, when moving to the standing position, the change in all haemodynamic variables, with the exception of SVR, were not significantly different between controls and those with T2DM when analysed by t-test or after ANCOVA correction for age, aortic PWV, fasting plasma glucose and seated HR (P40.05 for all). Furthermore, the results were not significantly changed after further adjustment for mean arterial pressure (data not shown).
Correlations of the change in BP The change in SVR and E A was significantly correlated with the change in both central and brachial SBP, (Figures 2 and 3a and b) in the controls only. In contrast, the change in SV when moving from the seated to standing posture was the only significant correlate of the change in central and brachial BP in patients withT2DM, and this was not observed in the controls. Z statistic scores were calculated to compare the correlation coefficients of postural changes to brachial and central SBP between controls and patients with T2DM. There were significant between-group differences in the strength of the relationship for the change in central SBP and change in SVR (z ¼ 3.5, Po0.01), E A (z ¼ 3.2, Po0.01) and SV (z ¼ 3.2, Po0.01), Figure 2 . The significant relationship with the change in central SBP remained for both the change in E A (r ¼ 0.52, P ¼ 0.03) and the change in SVR (r ¼ 0.56, P ¼ 0.02) after removal of an apparent outlier in healthy control subjects. In addition, significant differences in the strength of the relationship between the change in brachial SBP and change in SVR (z ¼ 2.7, P ¼ 0.01), E A (z ¼ 2.8, P ¼ 0.01) and SV (z ¼ 2.8, P ¼ 0.01) were also noted. (Figure 3 ). The relationship with the change in brachial SBP remained for both the change in E A (r ¼ 0.46, P ¼ 0.05) and the change in SVR (r ¼ 0.50, P ¼ 0.03) after removal of an apparent outlier in healthy control subjects.
DISCUSSION
The novel finding of this study was the different haemodynamic response of central BP upon standing between healthy individuals and those with type 2 diabetes. We noted a significant reduction in central PP upon standing in controls, which was different to brachial PP, and there was a significant correlation of central SBP ANCOVA corrected for *plus seated heart rate.
Central haemodynamics and postural stress MG Schultz et al with postural changes to both SVR and E A . In contrast, central and brachial PPs were significantly raised in patients with T2DM in both positions and there were no significant changes (in either central or brachial PP) when moving from the seated to standing position. Furthermore, the only correlate of change in central SBP was the change to SV, which was contrary to the control response. Raised central PP is an important predictor of cardiovascular and all-cause mortality.
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Therefore, differential postural haemodynamics resulting in persistently elevated central PP in seated and standing postures may contribute negatively to the health status of patients with T2DM who are already at heightened cardiovascular risk.
Haemodynamic response to standing: controls Postural stress, such as that encountered when moving from the seated to standing posture, triggers multiple reactions to maintain BP homoeostasis. The immediate response to standing from the seated or supine posture is a rapid transfer of blood volume to the lower extremities. This diminishes cardiac preload, leading to reductions in SV, CO and brachial BP. In order to maintain appropriate BP and organ perfusion, centrally located baroreceptors stimulate cardiac activity (with positive inotropic and chronotropic effects) and enhance peripheral vasoconstriction. 22 These acute changes tend to stabilise within B30 s, 23 by which time SV and brachial SBP may return to a level similar, or slightly lower, to that of seated, 23, 24 while heart rate remains slightly elevated. This response was observed in the controls of this current study. These individuals also had a slight, but statistically significant, reduction in SVR upon standing. It is generally accepted that lower limb vascular resistance increases upon standing, 25 however, the literature is equivocal with respect to the effect of standing on SVR. 6, 23, 24, 26 The central BP responses to standing remain less well characterised than those of brachial BP. In the current study, we hypothesised that central SBP would lower to a greater extent than brachial SBP due to increased SBP amplification from the increased HR associated with standing. While HR did significantly increase, there was no change in SBP amplification because both brachial and central SBP lowered to a similar extent (although nonsignificant). Despite this, central PP was significantly lower in the standing posture. While it has been demonstrated in pacing studies that an elevation in SBP amplification (and also a decrease in central PP) occurs with an increase in HR, 8 our data suggests this may not be the case in the setting of postural stress. Only one other study has aimed to determine the haemodynamics of central BP in response to standing, by comparing healthy older and younger subjects. 6 These investigators used finger photoplethysmography to estimate central BP and found that central SBP (and central PP) significantly decreased after standing from the supine position in the healthy young. 6 Interestingly, reductions in central BP and augmentation index occurred despite an overall increase in SVR. In control participants of the current study, the change in both brachial and central SBP were strong and positive correlates of the change in SVR (as was the change in E A ), despite an overall reduction upon standing. In agreement with others, 6, 23 this may suggest that systemic vascular properties and function have a fundamental role in the appropriate regulation of central BP upon standing in healthy individuals. While it remains to be confirmed, we propose that an appropriately functioning and compliant vascular system acts to buffer the increase in CO generated upon standing, thereby, minimising impedance to outflow and optimising central SBP (and PP) in the standing posture. 27 Haemodynamic response to standing: T2DM In contrast to control individuals, we found no significant reduction in central PP upon standing in patients with type 2 diabetes. While previous studies have reported increased risk for orthostatic hypotension in individuals with T2DM, 28 the persistent elevation of central PP is also an important finding, as a recent meta-analysis reported that elevated central PP is an independent predictor of all-cause and cardiovascular mortality. 4 The mechanisms underpinning the lack of central PP reduction in patients with T2DM is unclear, but it is of interest that the postural change in SV was highly correlated with both the change in brachial and the change in central SBP and this was not observed in the controls. The nonsignificant reduction in central PP only observed in patients with T2DM on standing is probably explained by the lack of significant reduction in SVR, coupled with relatively higher HR and CO when compared to the healthy controls. Taken in context with the control response to standing, this may suggest that maintenance of SBP in patients with type 2 diabetes is more influenced by increased CO output. Indeed, elevated CO (measured by cardiac magnetic resonance imaging) has been Figure 1 . The change in haemodynamic variables from the seated to standing posture in healthy controls (black shading) and individuals with type 2 diabetes (white shading). BSBP, brachial systolic blood pressure; BDBP, brachial diastolic blood pressure; BPP, brachial pulse pressure; CSBP, central systolic blood pressure; CPP, central pulse pressure; AIx, augmentation index; HR, heart rate; CO, cardiac output; SVR, systemic vascular resistance. Error bars are s.e. of the mean. *Po0.05 within groups.
reported in patients with insulin resistance and diabetes. 29 In the current study, HR increased (nonsignificantly) upon standing in individuals with T2DM, and we have previously noted that in older patients treated for hypertension, HR is a significant correlate of the change in central BP upon standing. 9 In addition, other studies have highlighted impaired heart rate variability and autonomic dysfunction in patients with T2DM, 30 which may reflect decreased vagally-mediated autonomic tone, 31 and supports our observation of increased HR and CO.
It is also commonly reported that in patients with T2DM, impaired vascular function (such as nitric oxide-mediated endothelial function), 11 and increased large-artery stiffness 32 contribute to the increased cardiovascular risk profile associated with the disease. In the current study, patients with T2DM had increased aortic PWV in the supine position compared with the controls. Although we did not measure PWV in the seated or standing postures, a previous study found that increased aortic PWV correlated with a lack of SBP reduction upon standing in older, non-diabetic individuals. 33 Furthermore, other studies have indicated that increased aortic stiffness and pulsatility of blood flow to the small arteries may alter vasoactive function. 34, 35 These observations could be of relevance to our findings in which SVR . These relationships were of borderline significance after adjustment for age, seated systolic BP and BMI (P ¼ 0.052 and P ¼ 0.083, respectively). Also note the significant relationship between change in central SBP and change in stroke volume in patients with T2DM, which was not evident in controls. All correlation coefficients were significantly different between controls and those with T2DM when compared by Z statistics.
and E A were unchanged upon standing and, in contrast to control individuals, were not associated with the change in central SBP.
Taken all-together, despite the insignificant change in SV, the increased HR, CO and altered vascular properties in patients with T2DM may hinder appropriate ventricular-vascular interaction upon standing, thus preventing significant reduction in central PP upon standing.
Limitations
Although we undertook comprehensive haemodynamic measurements, all procedures were non-invasive and may be subject to criticism of accuracy. However, the validity and reproducibility of all devices used has been previously reported. [16] [17] [18] [19] In addition, we only estimated SVR and this technique does not enable characterisation of regional vascular adaptations to postural changes, which may have been different to the systemic response. Furthermore, we only measured PWV in the supine position and the standing response may have provided additional insight into the haemodynamics of postural stress. Many of the patients with T2DM had comorbidities such as hypertension that required the use of medications. They also had a number of cardiovascular risk factors (increased age, body mass index (BMI) and PWV), which may have influenced haemodynamic and vascular responses to postural change. Although this clinical presentation may be typical of patients with T2DM, we did not . Note the significant relationship between the change in brachial SBP with the change in systemic vascular resistance and arterial elastance (E A ) in the controls, but not in patients with T2DM. These relationships were of borderline significance after adjustment for age, seated systolic BP and BMI (P ¼ 0.089 and P ¼ 0.058, respectively). Also note the significant relationship between change in brachial SBP and change in stroke volume in patients with T2DM, not evident in controls. All correlation coefficients were significantly different between controls and those with T2DM when compared by Z statistic.
attempt to control these variables in order to maximise external validity of the study. However, drug-naive individuals with T2DM, and fewer risk factors, may have different postural responses than that observed in this current study. The patient's with T2DM were not matched to controls for age or other clinical characteristics. While this is a potential limitation, the aim of this study was to characterise a healthy response to standing compared with a clinically representative population of individuals with T2DM. The modest sample size may also be a limiting factor of this study.
Summary and significance
This study has demonstrated a differential haemodynamic response to standing from the seated position between healthy individuals and those with T2DM. The main difference was that central PP was significantly reduced upon standing in healthy individuals, but not in those with type 2 diabetes. Moreover, the haemodynamic correlates of the change in central BP were significantly different between controls and patients with type 2 diabetes. In health, it appears that central SBP may be maintained by optimal integration of systemic vascular properties and left ventricular function, whereas in T2DM, increased SV (high output) may be more important for maintenance of central SBP. Raised central PP is an important predictor of cardiovascular and all-cause mortality. 4, 21 Our findings suggest that it is possible that differential postural haemodynamics resulting in persistently elevated central PP in seated and standing postures may contribute negatively to the health status of patients with T2DM, who are already at heightened cardiovascular risk. However, this speculation will need to be tested in other studies.
What is known about this topic
An abnormal change in blood pressure (BP) in response to postural stress (standing) is associated with increased cardiovascular risk. The underlying mechanisms are unknown but could be related to abnormal central BP responses.
What this study adds Compared with healthy individuals, patients with type 2 diabetes (T2DM) have different haemodynamic responses to standing, and have persistently elevated central pulse pressure. In terms of understanding factors responsible for maintenance of central BP while standing, optimal integration of systemic vascular properties and left ventricular function appears to have a role in healthy individuals, whereas increased stroke volume (high output) may be more important in patients with T2DM.
